Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06496230 · ClinicalTrials.gov registry record · Early Phase 1
Open Trial of Technology-Enhanced Behavioral Intervention for Buprenorphine Retention in Pregnant and Postpartum People
A Early Phase 1 study of Opioid Use Disorder and Pregnancy Related, sponsored by Medical University of South Carolina.
- Active
- Registry status
- Early Phase 1
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT06496230 is a Early Phase 1 study of Opioid Use Disorder and Pregnancy Related that is active but no longer recruiting, run by Medical University of South Carolina. The registered enrollment target is 26 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06496230, a Early Phase 1 study of Opioid Use Disorder and Pregnancy Related, is active but no longer recruiting, sponsored by Medical University of South Carolina.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
This study involves testing how useful a technology-enhanced intervention is for pregnant people prescribed buprenorphine for the management of opioid use disorder. The intervention being studied is a brief therapy protocol and a mobile application. Participation involves four 60-minute therapy appointments during pregnancy, and four 30-minute therapy appointments at the end of pregnancy through 3 months postpartum. The mobile application will be accessible for at least the duration of the study. Participants will also be asked to complete questionnaires at enrollment and again at 1-month postpartum and 3-months postpartum, will send monthly photos of their prescription bottle/box, and will be contacted randomly throughout the study to perform a medication count. The total duration of the study is between 5-9 months depending on when you enroll (early second trimester-mid third trimester). Compensation is provided.
Conditions Studied
Interventions
- BEHAVIORAL Empowering Pregnant Women and People Receiving Medications for Opioid Use Disorder
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2024-08-06 |
| Est. Completion | 2026-01-31 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06496230
The ClinicalTrials.gov registry entry for NCT06496230 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Empowering Pregnant Women and People Receiving Medications for Opioid Use Disorder is the first listed.
NCT06496230 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT06496230 about?
NCT06496230 is a clinical study titled "Open Trial of Technology-Enhanced Behavioral Intervention for Buprenorphine Retention in Pregnant and Postpartum People". This study involves testing how useful a technology-enhanced intervention is for pregnant people prescribed buprenorphine for the management of opioid use disorder. The intervention being studied is a brief therapy protocol and a mobile application. Participation involves four 60-minute therapy appo...
What is the current status of trial NCT06496230?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 26 participants. The study started on 2024-08-06. Estimated completion is 2026-01-31.
What conditions does trial NCT06496230 study?
This clinical trial studies the following conditions: Opioid Use Disorder, Pregnancy Related.
What interventions are being tested in trial NCT06496230?
The interventions under investigation include: Empowering Pregnant Women and People Receiving Medications for Opioid Use Disorder (BEHAVIORAL).
Who is sponsoring clinical trial NCT06496230?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06496230 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Clinical Trial Comparing Buprenorphine Formulations for High Potency Synthetic Opioid Use
RECRUITING · Early Phase 1
-
Cannabidiol in Opioid Use Disorder and Chronic Pain
RECRUITING · Early Phase 1
-
Behavioral Effects of Drugs (Inpatient): 43 (Opioids, Cocaine, n-Acetylcysteine)
RECRUITING · Early Phase 1
-
Enhancing Prospective Thinking in Early Recovery (PARK)
COMPLETED · Early Phase 1
-
Opioid Treatment Program (OTP)-Pharmacy Collaboration for Methadone Maintenance Treatment
COMPLETED · Early Phase 1
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.